RxDoctor Payments Data

Kusum Singh, MD

Family Medicine · Alliance, OHNPI 1881696771

Payments from drug & device makers

$1,971in general payments, 2019–2025

Across 93 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$856
  • Boehringer Ingelheim$212
  • Pfizer$207
  • AbbVie$176
  • Amarin Pharma, Inc.$133
  • Merck$91
  • plus $297 from 10 others

What the payments were for

  • Food & beverage$1,971100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,971 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$11,820
Medicare patients
58
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin14$15,509
Rosuvastatin Calcium17$396
Losartan Potassium21$385
Metoprolol Succinate13$283
Atorvastatin Calcium49$250
Amlodipine Besylate25$214
Escitalopram Oxalate14$143
Levothyroxine Sodium21$138
Pantoprazole Sodium21$113
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide14$96
Diazepam17$86
Metformin Hcl14$78
Citalopram HbrCitalopram Hydrobromide12$59
Atenolol11$51
Metformin Hcl ErMetformin Hcl12$50

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$212$15,50914 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$13821 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Alliance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →